BLU3 Unveils the Revolutionary SeaNXT Elite at the Miami Boat Show AquaZone – Live Demos, Cutting-Edge Design, and Opportunities for Partnerships Await!
MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...